Endocrine Gland Neoplasm
4 clinical trials · Condition
◉ Watch Endocrine Gland Neoplasm
| Record | Firm | Date |
|---|---|---|
| OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. (NCT04493632) | OncoSil Medical Limited | 2022-04-12 |
| Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer (NCT03562897) | Catalysis SL | 2018-10-25 |
| Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors (NCT03037385) | Hoffmann-La Roche | 2017-03-17 |
| Assessing the Patient Experience in Cancer Care (NCT01621295) | Mayo Clinic | 2012-05-01 |
Track Endocrine Gland Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.